This growth was driven in product sales of 1.4 million units and a rise in provincial orders of 8%, despite falling sales in the first two months of the quarter.
There’s speculation building that Valens could use this capital to expand into the United States.
These Cannabis 2.0 products span a range of value-added products, including vapes and edibles, and are extremely popular among consumers.
Additionally, Valens introduced other innovative 2.0 products, including high-potency CBD-dominant oil.
With an impressive catalog of pioneering product launches, speculative investors may want to consider this stock.
The online investing service they’ve run since 2013, Motley Fool Stock Advisor Canada, has beaten the stock market by over 3X.
This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor.
I consent to receiving information from The Motley Fool via email, direct mail, and occasional special offer phone calls.